MyAverix Finance
TWO · Healthcare
General Biologicals Corporation (4117)
Drug Manufacturers - Specialty & Generic
General Biologicals Corporation (4117) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4117
General Biologicals Corporation (4117) — FAQ
What is 4117's P/E ratio?
The price-to-earnings (P/E) ratio for General Biologicals Corporation (4117) is 18.00 (data as of 2026-03-23).
Does General Biologicals Corporation pay a dividend?
Dividend yield is not available in the current snapshot for General Biologicals Corporation (4117). Check the MyAverix Finance app for the latest dividend data.
What sector is General Biologicals Corporation in?
General Biologicals Corporation (4117) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 4117 listed on?
4117 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.